They slow gastric emptying, increase satiety, act on appetite signaling in the brain, and enhance glucose-dependent insulin secretion
Find out more: How we vet brands and products July 10, 2026: Most Weight-Loss Drugs Do Not Improve Quality of Life or Heart Health July 6, 2026: Generic Mounjaro, Zepbound May Be Coming, Rivaling Current GLP-1s June 29, 2026: GLP-1s Like Ozempic, Mounjaro Linked to Reduced Stroke, Heart Risk June 26, 2026: Can GLP-1 Weight Loss Drugs Give Athletes an Unfair Advantage
It could help the more than 70 million adults in the United States who struggle with this chronic condition, says Ildiko Lingvay, M.D., M.P.H., M.S.C.S., professor of internal medicine and population and data sciences at UTSW and lead author of the study, published today in The Lancet
Improves Insulin Sensitivity Helps the body use insulin more effectively, improving blood sugar regulation